4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0000899243-22-036018
General Counsel sold 2,358 shares at $8.91 ($21,018)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Miller Edward General Counsel | 2022-11-14 | Sale | −2,358 | $8.91 | $21,018 | 190,453 | I: show line 1 in the form |
| Open-market sales · 2,358 sh · avg $8.91 · $21,018 | |||||||
Loading xslF345X03/doc4.xml…